Date and time: Monday, May 04, 2009 at 10:00 AM View this event on Windows Live
Traditionally, we trust doctors with confidential information about our health in the knowledge that it’s in our own interests. Similarly, few patients object to the idea that such information may be used in some form for medical research. But what happens when this process is subject to scrutiny?
How explicit does our consent have to be? Since the introduction of the Data Protection Act 1998 medical researchers have raised concerns over the increasing barriers they face to accessing patient data.
RECORDED ON 11/08 IN LONDON, U.K.
[As our nation (U.S.) attempts to addess and solve healthcare issues, several insigtful arguments pro and con were presented of which we have yet to consider.]
At the heart of the debate lie key questions over trust and consent and how these can best be resolved.
To complicate things, it is no longer just medical researchers, but also public health bureaucrats who are keen to have access to our data.
Social Marketing – the borrowing of commercial marketing techniques in the pursuit of ‘public goods’ – is in vogue amongst public health officials. Empowered by advanced data collection and computing techniques, armed with the latest epidemiological research, and emboldened by a mission to change unhealthy behaviour, public health officials are keen to target their messages to specific ‘market segments’ in most need of advice.
Are government researchers abusing patients’ trust?
Can and should a distinction be made between the use of data for research and public health promotion purposes, or do the benefits of data-sharing outweigh its disadvantages?